Revenue
€5,711,189
2024 · latest filed year
Employees
32
2026-06
Average wage
€7,618
monthly, before tax
Tax arrears
No recorded arrears
No data
Company overview
AI researchA source-linked overview of the company's activities based on public information.
UAB Merck Sharp & Dohme is MSD’s biopharmaceutical company in Lithuania, supplying medicines and vaccines and supporting scientific and medical-information work in oncology, vaccines, infectious diseases and cardiometabolic conditions.
Primary activity
Products and services
Sources
Researched: 24 August 2026 · Confidence: High · This overview was prepared by AI. Verify important claims with the linked primary sources.
Registry information
- Company code
- 111834114
- Legal form
- Private Limited Liability Company
- Status
- No legal proceedings
- Registered
- 31 December 2003
- Municipality
- Vilniaus miesto
- Registered office
- Vilnius, Kęstučio g. 59, LT-08124
- Office registered since
- 2 March 2007
- Office data updated
- 7 August 2026
Insolvency proceedings
Official AVNT company bankruptcy and restructuring data. Administrator identities and contact details are not shown.
- Active proceeding
- No
- Proceedings on record
- 0
VAT information
- VAT registered
- Yes
- VAT number
- LT118341113
- VAT registered on
- 1 February 2004
- Of which overdue
- €0
Primary activity
- EVRK code
- 702200
- Primary activity
- Not provided
- Employees
- 32 (2026-06)
- Average wage
- €7,618
Participant structure
Only aggregate participant counts are published, without personal data.
- Total participants
- 1
- Lithuanian natural persons
- 0
- Lithuanian legal persons
- 0
- Foreign natural persons
- 0
- Foreign legal persons
- 1
- Has foreign participants
- Yes
Online presence
A website and its published information are shown only after its link to the legal entity is verified.
No verified company website has been found yet.
Tax and public procurement
A summary of taxes paid from VMI and contracts published by the Public Procurement Office.
- Taxes paid year to date
- €408,445
- Reporting period
- June 2026
- Public contracts
- 0
- Total contract value
- —
- Latest contract
- —
Financials
Key figures from the company's filed annual financial statements.
| Year | Revenue | Profit before tax | Net profit | Total assets | Equity |
|---|---|---|---|---|---|
| 2024 | €5,711,189 | €576,393 | €457,119 | €2,953,104 | €1,124,781 |
| 2023 | €4,415,311 | €424,258 | €343,761 | €2,398,242 | €667,662 |
| 2022 | €3,781,095 | €325,758 | €256,684 | €5,142,991 | €4,323,901 |
| 2021 | €3,230,392 | €293,964 | €247,954 | €4,758,150 | €4,067,213 |
| 2020 | €2,697,577 | €267,975 | €224,618 | €4,337,378 | €3,819,258 |
| 2019 | €3,188,983 | €318,127 | €263,505 | €4,148,604 | €3,594,638 |
Filed: 14 May 2025
Similar companies
Active companies in the same sector, ranked by latest revenue.
Activities of head offices; management consultancy activitiesVilniaus miestoActivities of head offices; management consultancy activities · Vilniaus miesto
Sources: State Enterprise Centre of Registers, VMI, Sodra and the Public Procurement Office. Website ownership is checked against .lt domain data and legal-entity details published on the website. Open data is licensed under CC BY 4.0.